CORD-19:932bcdd2f6c6d487386e8bf983e4874387771be1 / 393087-393295 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"T36649","span":{"begin":0,"end":208},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Administration of Smad7-antisense-oligonucleotides (Smad7-as) in vivo ameliorated clinical signs of active and adoptively transferred experimental autoimmune encephalomyelitis and diminished CNS inflammation."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T48","span":{"begin":0,"end":208},"obj":"Sentence"}],"text":"Administration of Smad7-antisense-oligonucleotides (Smad7-as) in vivo ameliorated clinical signs of active and adoptively transferred experimental autoimmune encephalomyelitis and diminished CNS inflammation."}

{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T1327","span":{"begin":191,"end":194},"obj":"Body_part"}],"attributes":[{"id":"A1327","pred":"uberon_id","subj":"T1327","obj":"http://purl.obolibrary.org/obo/UBERON_0001017"}],"text":"Administration of Smad7-antisense-oligonucleotides (Smad7-as) in vivo ameliorated clinical signs of active and adoptively transferred experimental autoimmune encephalomyelitis and diminished CNS inflammation."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T2552","span":{"begin":134,"end":175},"obj":"Disease"},{"id":"T2553","span":{"begin":158,"end":175},"obj":"Disease"},{"id":"T2554","span":{"begin":195,"end":207},"obj":"Disease"},{"id":"T53900","span":{"begin":134,"end":175},"obj":"Disease"},{"id":"T10390","span":{"begin":158,"end":175},"obj":"Disease"},{"id":"T71040","span":{"begin":195,"end":207},"obj":"Disease"}],"attributes":[{"id":"A2552","pred":"mondo_id","subj":"T2552","obj":"http://purl.obolibrary.org/obo/MONDO_0005134"},{"id":"A2553","pred":"mondo_id","subj":"T2553","obj":"http://purl.obolibrary.org/obo/MONDO_0005156"},{"id":"A2554","pred":"mondo_id","subj":"T2554","obj":"http://purl.obolibrary.org/obo/MONDO_0021166"},{"id":"A30077","pred":"mondo_id","subj":"T53900","obj":"http://purl.obolibrary.org/obo/MONDO_0005134"},{"id":"A28855","pred":"mondo_id","subj":"T10390","obj":"http://purl.obolibrary.org/obo/MONDO_0005156"},{"id":"A90203","pred":"mondo_id","subj":"T71040","obj":"http://purl.obolibrary.org/obo/MONDO_0021166"}],"text":"Administration of Smad7-antisense-oligonucleotides (Smad7-as) in vivo ameliorated clinical signs of active and adoptively transferred experimental autoimmune encephalomyelitis and diminished CNS inflammation."}